Quotes for Redwood Pharma AB
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Martin Vidaeus
Chairperson of the Board
- Gunnar Mattsson
Board
- Hans Ageland
- Ingrid Atteryd-Heiman
- Martin Vidaeus
- Mats Lidgard
Redwood Pharma is a pharmaceutical company. The main focus is on the production of ophthalmic pharmaceuticals. The products contain active substances that are used in the treatment of dry eye disease (DED), characterised by dryness, pain, and burning. The disorder is caused by inflammation due to dysfunction of the glands as well as by the usage of contact lenses. The company is based in Stockholm.
CEO
Chairperson of the Board
Board
Name | Capital % | Votes % | Date |
---|---|---|---|
Avanza Pension | 4,27 | 4,27 | 2024-03-26 |
Arne Andersson | 3,68 | 3,68 | 2024-03-26 |
Oleg Sutjagin | 3,01 | 3,01 | 2024-03-26 |
Bo Johan Peter Lundin | 1,95 | 1,95 | 2024-03-26 |
Michael Hedegaard | 1,88 | 1,88 | 2024-03-26 |
Lennart Starby | 1,61 | 1,61 | 2024-03-26 |
Sound & Vision Support I Sverige | 1,41 | 1,41 | 2024-03-26 |
Jens Erik Bechmann | 1,34 | 1,34 | 2024-03-26 |
Martin Johem | 1,32 | 1,32 | 2024-03-26 |
Christian Lentz | 1,32 | 1,32 | 2024-03-26 |